Carna Biosciences News

Carna Biosciences: Notice of sponsorship provision to CLL Society (US)

Nov 7 02:00 ET

Carna Biosciences: Notice of presentation at the American Society of Hematology (ASH) Annual Meeting on the BTK inhibitor docirbrutinib (AS-1763)

Nov 6 02:00 ET

Carna Biosciences: Notice of determination of the International Drug Name (INN) for AS-1763

Nov 5 02:00 ET

Carna Biosciences: Notice of commencement of BTK inhibitor AS-1763 phase 1b test dose expansion part administration

Oct 21 02:30 ET

Carna Biosciences: Share Transfer Report Relating to Third-Party Allocation (New Shares)

Oct 18 03:00 ET

Carna Biosciences: Stock transfer report agreement relating to third party allotment (new shares)

Oct 11 02:30 ET

Carna Biosciences: Notice of decision to start BTK inhibitor AS-1763 phase 1b test dose expansion part

Sep 2 03:00 ET

Carna Biosciences: Notice of patent assessment in Europe relating to a joint patent application with Gilead Sciences

Aug 27 02:30 ET

Carna Biosciences: Report of transfer of new shares for third-party allotment.

Aug 1 03:00 ET

Carna Biosciences: Announcements of individual stocks regarding patent assessment in China for BTK inhibitor AS-1763 pharmaceutical composition.

Jun 27 02:30 ET

Carna Biosciences: Promising initial data from the phase 1b clinical trial of the next-generation BTK inhibitor AS-1763 targeting mature B-cell tumors will be presented at the European Hematology Association (EHA) in 2024.

Jun 17 02:30 ET

Carna Biosciences: Stock transfer report agreement relating to third party allotment (new shares)

May 31 02:30 ET

Carna Biosciences: Notice of presentation at European Society of Hematology (EHA) 2024 on BTK inhibitor AS-1763

May 15 04:30 ET

Carna Biosciences: Outline of the poster presentation at the American Cancer Society (AACR) annual meeting on the CDC7 inhibitor monzosertib

Apr 10 02:30 ET

Carna Biosciences: Notice of presentation at the American Cancer Society (AACR) annual meeting on the CDC7 inhibitor monzosertib

Mar 12 02:30 ET

Carna Biosciences: End of license agreement with Fresh Trax Therapeutics

Mar 5 02:00 ET

Carna Biosciences: Announcement of joint research paper with the Cancer Research Group

Mar 4 02:00 ET

Carna Biosciences: Independent Officer Registration Form

Mar 4 01:30 ET

Carna Biosciences: Notice regarding executive personnel

Feb 22 01:30 ET

Carna Biosciences: Notice regarding the introduction of a post-issuance performance-linked stock reward system (performance share unit system)

Feb 22 01:30 ET